Raymond Gambino
Raymond Gambino publishes mostly in Endocrinology, Diabetes and Metabolism, Molecular Biology and Pediatrics, Perinatology and Child Health, on topics such as Diabetes Management and Research, Metabolism, Diabetes, and Cancer and Hyperglycemia and glycemic control in critically ill and hospitalized patients.
- World rank
- #5,371,464 of 7,710,434 ranked researchers
- Rank in United States
- #1,364,724 of 1,627,098
- Works
- 43
- Citations
- 647
- Citations per work
- 15.0
What does Raymond Gambino research?
Raymond Gambino's work is mostly in Medicine (39%), Biochemistry, Genetics and Molecular Biology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else2352.4%
- Health Sciences1739.0%
- Medicine1739.0%
- Life Sciences48.6%
- 1Endocrinology, Diabetes and Metabolism15% of their works
- 2Molecular Biology9% of their works
- 3Pediatrics, Perinatology and Child Health8% of their works
- 4Physiology6% of their works
- 5Epidemiology6% of their works
- 6Surgery5% of their works
Research topics
- Diabetes Management and Research
- Metabolism, Diabetes, and Cancer
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Liver Disease Diagnosis and Treatment
- Clinical Laboratory Practices and Quality Control
- Hemoglobinopathies and Related Disorders
- Peroxisome Proliferator-Activated Receptors
- Diabetes, Cardiovascular Risks, and Lipoproteins
Which keywords describe Raymond Gambino's research?
The keywords of their largest research topics: Diabetes, Glycemic Control, Insulin Therapy, Cardiovascular Disease, Insulin Resistance, Metabolic Syndrome, Continuous Glucose Monitoring and Hypoglycemia.
- PPARs
- Atherosclerosis
- Sickle-cell Disease
- Preanalytical Variables
- NAFLD
- Hyperglycemia
- AMP-Activated Protein Kinase
- Hypoglycemia
- Metabolic Syndrome
- Cardiovascular Disease
- Glycemic Control
- Diabetes
- Insulin Therapy
- Insulin Resistance
- Continuous Glucose Monitoring
- Obesity
- Critical Care
- Metformin
- NASH
- Reference Intervals
- Thalassemia
- Glucose Metabolism
- Peroxisome Proliferator-Activated Receptors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Diabetes123 topics
- Glycemic Control112 topics
- Insulin Therapy112 topics
- Cardiovascular Disease92 topics
- Insulin Resistance82 topics
- Metabolic Syndrome82 topics
- Continuous Glucose Monitoring61 topic
- Hypoglycemia61 topic
- Obesity62 topics
- AMP-Activated Protein Kinase51 topic
- Critical Care51 topic
- Hyperglycemia51 topic
- Metformin51 topic
- NAFLD51 topic
- NASH51 topic
- Preanalytical Variables51 topic
- Reference Intervals51 topic
- Sickle-cell Disease41 topic
- Thalassemia41 topic
- Atherosclerosis31 topic
- Glucose Metabolism31 topic
- PPARs31 topic
- Peroxisome Proliferator-Activated Receptors31 topic
Where does Raymond Gambino work?
Raymond Gambino's main affiliation in the publication record is Quest Diagnostics (United States), United States.
How many publications and citations does Raymond Gambino have?
OpenAlex counts 43 works and 647 citations for Raymond Gambino, an h-index of 10, ranking #5,371,464 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Raymond Gambino. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.